Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Pediatr Blood Cancer ; 66(5): e27597, 2019 05.
Article in English | MEDLINE | ID: mdl-30604473

ABSTRACT

Shwachman-Diamond syndrome (SDS) is one of the more common inherited bone marrow failure syndromes, characterized by neutropenia, occasional thrombocytopenia, and anemia. Bone marrow evaluation reveals an increased number of monocytes and mature B cells along with decreased granulocytes. However, little is known about the subpopulations of peripheral blood cells, and few previous publications have been based on a small number of patients. Here, we report a comprehensive immunophenotypic analysis from a cohort of 37 SDS patients who display impairment mostly in the myeloid compartment with a deficiency also in the number of B cells and CD4/CD8 double-negative T cells.


Subject(s)
B-Lymphocytes/immunology , Bone Marrow Diseases/blood , Bone Marrow Diseases/immunology , Exocrine Pancreatic Insufficiency/blood , Exocrine Pancreatic Insufficiency/immunology , Immunophenotyping/methods , Leukocytes, Mononuclear/immunology , Lipomatosis/blood , Lipomatosis/immunology , Adolescent , Adult , Bone Marrow Diseases/pathology , Case-Control Studies , Child , Child, Preschool , Cohort Studies , Exocrine Pancreatic Insufficiency/pathology , Female , Follow-Up Studies , Humans , Infant , Lipomatosis/pathology , Male , Prognosis , Shwachman-Diamond Syndrome , Young Adult
2.
Am J Hematol ; 90(8): 702-8, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25963299

ABSTRACT

Immune function abnormalities have been reported in patients with Fanconi anemia (FA), dyskeratosis congenita (DC) and, rarely, in Shwachman-Diamond syndrome (SDS), and Diamond-Blackfan anemia (DBA), but large systematic studies are lacking. We assessed immunological parameters in 118 patients with these syndromes and 202 unaffected relatives. We compared the results in patients with reference values, and with values in relatives after adjusting for age, sex, corticosteroid treatment, and severe bone marrow failure (BMF). Adult patients (≥18 years) with FA had significantly lower immunoglobulins (IgG, IgA and IgM), total lymphocytes, and CD4 T cells than reference values or adult relatives (P < 0.001); children with FA had normal values. Both children and adults with FA had lower B- and NK cells (P < 0.01) than relatives or reference values. Patients with DC had essentially normal immunoglobulins but lower total lymphocytes than reference values or relatives, and lower T-, B-, and NK-cells; these changes were more marked in children than adults (P < 0.01). Most patients with DBA and SDS had normal immunoglobulins and lymphocytes. Lymphoproliferative responses, serum cytokine levels, including tumor necrosis factor-α and interferon-γ, and cytokine levels in supernatants from phytohemagglutinin-stimulated cultures were similar across patient groups and relatives. Only patients with severe BMF, particularly those with FA and DC, had higher serum G-CSF and Flt3-ligand and lower RANTES levels compared with all other groups or relatives (P < 0.05). Overall, immune function abnormalities were seen mainly in adult patients with FA, which likely reflects their disease-related progression, and in children with DC, which may be a feature of early-onset severe disease phenotype.


Subject(s)
Anemia, Diamond-Blackfan/diagnosis , Bone Marrow Diseases/diagnosis , Dyskeratosis Congenita/diagnosis , Exocrine Pancreatic Insufficiency/diagnosis , Fanconi Anemia/diagnosis , Hemoglobinuria, Paroxysmal/diagnosis , Lipomatosis/diagnosis , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Anemia, Aplastic , Anemia, Diamond-Blackfan/drug therapy , Anemia, Diamond-Blackfan/immunology , Anemia, Diamond-Blackfan/pathology , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Bone Marrow Diseases/congenital , Bone Marrow Diseases/drug therapy , Bone Marrow Diseases/immunology , Bone Marrow Failure Disorders , Case-Control Studies , Child , Child, Preschool , Cytokines/biosynthesis , Cytokines/immunology , Dyskeratosis Congenita/drug therapy , Dyskeratosis Congenita/immunology , Dyskeratosis Congenita/pathology , Exocrine Pancreatic Insufficiency/congenital , Exocrine Pancreatic Insufficiency/drug therapy , Exocrine Pancreatic Insufficiency/immunology , Family , Fanconi Anemia/drug therapy , Fanconi Anemia/immunology , Fanconi Anemia/pathology , Female , Granulocyte Colony-Stimulating Factor/biosynthesis , Granulocyte Colony-Stimulating Factor/immunology , Hemoglobinuria, Paroxysmal/congenital , Hemoglobinuria, Paroxysmal/drug therapy , Hemoglobinuria, Paroxysmal/immunology , Humans , Immunoglobulins/biosynthesis , Infant , Interferon-gamma/biosynthesis , Interferon-gamma/immunology , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Killer Cells, Natural/pathology , Lipomatosis/congenital , Lipomatosis/drug therapy , Lipomatosis/immunology , Male , Membrane Proteins/biosynthesis , Membrane Proteins/immunology
3.
Musculoskelet Surg ; 96(2): 81-8, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22201042

ABSTRACT

Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disorder with exocrine pancreatic insufficiency, bone marrow failure and skeletal abnormalities. Patients frequently present failure to thrive, susceptibility to infections and short stature. A persistent or intermittent neutropenia occurs in 88-100% of patients. Bone marrow biopsy usually reveals a hypoplastic specimen with varying degrees of hypoplasia and fat infiltration. Some patients may develop myeloblastic syndrome and acute myeloblastic leukemia. The genetic defect in SDS has been identified in 2002. The osteoporosis is increased in patients with SDS, and also, bone malformations are included among the primary characteristics of the syndrome. The severity and location change with age and sexes. The typical characteristics include the following: secondary ossification centers delayed appearance, metaphysis enlargement and irregularity (very common in childhood, particularly in coastal and femur), growth cartilage progressive thinning and irregularity (possibly asymmetric growth), generalized osteopenia with cortical thinning. We describe a clinical case regarding an SDS patient with severe bone abnormalities and treated surgically for corrective osteotomy. The persistent or intermittent neutropenia that characterized this disease and the consequent risk of infection is a contraindication for short stature correction and limbs lengthening.


Subject(s)
Bone Marrow Diseases/pathology , Exocrine Pancreatic Insufficiency/pathology , Lipomatosis/pathology , Lower Extremity Deformities, Congenital/surgery , Osteotomy/methods , Tibia/surgery , Adolescent , Antibiotic Prophylaxis , Bone Marrow Diseases/immunology , Child, Preschool , Contraindications , Dwarfism/genetics , Exocrine Pancreatic Insufficiency/immunology , External Fixators , Granulocyte Colony-Stimulating Factor/therapeutic use , Humans , Immunocompromised Host , Lenograstim , Lipomatosis/immunology , Locomotion , Lower Extremity Deformities, Congenital/genetics , Male , Neutropenia/drug therapy , Neutropenia/genetics , Orthopedic Procedures , Osteotomy/instrumentation , Phenotype , Preoperative Care , Recombinant Proteins/therapeutic use , Shwachman-Diamond Syndrome , Tibia/pathology
4.
Exp Clin Endocrinol Diabetes ; 119(10): 610-2, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21553366

ABSTRACT

Shwachman-Diamond syndrome is a rare clinical condition consisting of exocrine pancreatic dysfunction, various degree of pancytopenia, and metaphyseal dysplasia. The majority of Shwachman-Diamond syndrome cases result from mutations in the Shwachman-Bodian-Diamond Syndrome gene. To date, type 1 diabetes mellitus has only been reported in 4 independent cases presenting with Shwachman-Diamond syndrome, 3 of them with molecular confirmation of the diagnosis. We describe 2 unrelated patients with clinical and molecular features typical of Shwachman-Diamond syndrome and type 1 diabetes mellitus. In addition, we report the occurrence rate of type 1 diabetes mellitus in the Italian registry for Shwachman-Diamond syndrome, which is low (3.23%) but increased at least 30-fold over the type 1 diabetes mellitus occurrence rate in the general population. No evidence of a direct correlation between Shwachman-Diamond syndrome and type 1 diabetes mellitus have been reported, therefore the presence of both diseases in the same patient might be a chance association, however we suggest that the defects in immune regulation of Shwachman-Diamond syndrome might play a role in the development of type 1 diabetes mellitus.


Subject(s)
Bone Marrow Diseases/complications , Diabetes Mellitus, Type 1/complications , Exocrine Pancreatic Insufficiency/complications , Lipomatosis/complications , Bone Marrow Diseases/genetics , Bone Marrow Diseases/immunology , CD4-CD8 Ratio , Diabetes Mellitus, Type 1/etiology , Exocrine Pancreatic Insufficiency/genetics , Exocrine Pancreatic Insufficiency/immunology , Female , Heterozygote , Humans , Immune System/physiopathology , Infant , Italy/epidemiology , Lipomatosis/genetics , Lipomatosis/immunology , Male , Mutation , Prevalence , Proteins/genetics , Registries , Shwachman-Diamond Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...